CHICAGO -- December 2, 2013 -- GE Healthcare, a unit of General Electric Company (NYSE: GE), is dedicated to providing clinicians worldwide with leading radiation dose management innovations. X-ray dose is a critical issue and GE Healthcare has collaborated with top institutions to develop strategies to better manage it. At this year's 2013 Radiological Society of North America (#RSNA13) annual meeting, GE Healthcare is showcasing several new offerings to enable low-dose imaging procedures and help clinicians track and measure dose.
Revolution CT to give clinicians a test that gives them outstanding image quality and reduced dose exposure for patients
CHICAGO -- DECEMBER 2, 2013 -- GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced at the Radiological Society of North America's 99th Scientific Assembly and Annual Meeting in Chicago, Illinois that its 510(k)-pending Revolution CT^ has captured a motion free image of the human heart in just one beat.
business unit
tags
CHALFONT ST. GILES, UK -- 19 November 2013 -- GE Healthcare Life Sciences, (NYSE: GE) and Cellectis Group (Alternext: ALCLS), the global genome engineering specialist, announced today that GE Healthcare has licenced Cellectis to develop, manufacture and sell models derived from stem cells for use in drug discovery and toxicity screening.
business unit
tags
GE announced third-quarter 2013 operating earnings of $3.7 billion, or $0.36 per share, down 3% and flat respectively from the third quarter of 2012.
Please click here to read the rest of the press release, in English.
Corporate Communications
[email protected]
business unit
tags
* Consumer awareness and cultural barriers surrounding screening putting lives at risk
* 15 million years of 'healthy life' were lost worldwide in 2008 due to women dying early or being ill with the disease
Chalfont St. Giles, U.K. --- October 15, 2013. Rising breast cancer incidence and mortality represent a significant and growing threat for the developing world, according to a new global study commissioned by GE Healthcare.